北美医药中间体市场预测至 2028 年 - COVID-19 影响和按类型(GMP 和非 GMP)、应用(抗生素、解热镇痛药、维生素等)和分销渠道(分销商和直销)进行的区域分析

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 115    |    Report Code: TIPRE00025456    |    Category: Life Sciences

North America Pharmaceutical Intermediates Market

市场介绍

北美由三个主要国家组成,即美国、加拿大、墨西哥。还对北美其他市场进行了评估。美国和加拿大等国家市场的增长是由生产原料药的医药中间体需求不断增加、通过提高药品生产的举措不断增加的支持以及生物制药行业的研发不断增加等因素推动的。此外,墨西哥等国家不断增长的制药业预计将在预测期内为市场提供增长机会。美国是全球最大的医药中间体市场。该市场的增长归因于产品开发的增加、仿制药产量的增加以及政府对加强制药和生物制药行业的支持不断增加。此外,慢性病和急性病发病率的不断上升也间接导致了市场的增长。慢性病和传染病患病率的增加是推动北美医药中间体市场增长的主要因素。

自COVID-19爆发以来,北美的病例数量不断增加。例如,根据 Worldometer 的数据,截至 2021 年 4 月,美国的病例数增加至 31,990,143 例,死亡人数为 576,298 人。墨西哥和加拿大的病例数也在增加。截至 2021 年 4 月,墨西哥的病例已达到 2,281,840 例,死亡人数为 209,702 人。同样,在加拿大,截至 2021 年 4 月报告的新冠肺炎病例约为 1,071,016 例。这一流行病正在给全球公共卫生系统带来压力,中断和推迟了许多类型的治疗。关键的医疗保健。世界卫生组织最近的一项调查发现,卫生服务是最常受到干扰的服务之一。全球十分之七的国家以及美国、加拿大和墨西哥都正在经历中断。然而,根据 IRI 的数据,美国新冠病毒大流行爆发后,对各种膳食补充剂的需求以前所未有的速度激增。 2020 年 3 月第一周,补充剂总销售额增长了 6%。此外,由于保持社交距离,消费者的日常美容和皮肤护理正在发生变化。这导致对可在家使用的营养产品的需求增加。此外,新冠患者发病率的上升增加了北美地区对镇痛药的需求。

市场概况和动态

<北美医药中间体市场预计将从2021年的110.5447亿美元增长到2028年的149.2732亿美元;预计 2021 年至 2028 年复合年增长率为 4.4%。墨西哥等国家正在成为制药和生物制药行业有吸引力的外包地点。该国较低的制造和运营成本是推动该地区药品制造业务的关键因素。制药行业近期的增长表明医药中间体市场前景乐观。该地区蓬勃发展的国内医药市场和不断增加的管道药品数量进一步为该地区的合同制造商和仿制药生产开辟了新的途径。此外,为了满足不断增长的需求,许多合同组织正在扩大其制造能力,进一步推动市场的增长。因此,新兴市场为北美地区的制药公司提供了巨大的潜力和巨大的创收机会。

关键细分市场

北美医药中间体市场根据类型、应用、分销渠道和国家进行细分。根据类型,市场分为 GMP 和非 GMP。 2020 年,GMP 领域在市场上占据主导地位,预计将在预测期内增长最快。根据应用,医药中间体市场分为抗生素、解热镇痛药、维生素等。其他细分市场在 2020 年占据市场主导地位,维生素细分市场预计将在预测期内增长最快。根据分销渠道,医药中间体市场分为经销商和直销。直销细分市场在 2020 年占据主导地位,分销细分市场预计将在预测期内增长最快。

主要来源和上市公司

准备本北美医药中间体市场报告时参考的一些主要一手和二手资料包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有巴斯夫股份公司(BASF SE);奇拉康有限公司;法典; Dishman Carbogen Amcis 有限公司;迈达斯制药有限公司;辉瑞公司;赛诺菲; Vertellus Holdings LLC 就是其中之一

购买报告的理由< /strong>

  • 了解北美医药中间体市场格局,并确定最有可能保证丰厚回报的细分市场
  • 通过了解北美医药中间体市场不断变化的竞争格局
  • 通过识别最有前景的细分市场,有效规划北美医药中间体市场的并购和合作交易  
  • 通过对北美医药中间体市场各个细分市场的市场表现进行敏锐和全面的分析,有助于做出明智的业务决策
  • 获取北美地区 2021-2028 年各个细分市场的市场收入预测.

北美医药中间体市场细分

北美医药中间体市场 -By类型

  • GMP
  • 非GMP

北美医药中间体市场-按

应用

  • 抗生素
  • 解热镇痛药
  • 维生素
  • 其他

北美医药中间体市场 - 按分销渠道

  • 分销商
  • < span>直接销售

北美医药中间体市场 - 按国家/地区

  • 美国
  • 加拿大
  • 墨西哥

北美医药中间体市场-

< strong>公司简介

  • 巴斯夫股份公司
  • chiracon GmbH
  • Codexis
  • Dishman Carbogen Amcis Ltd
  • Midas Pharma GmbH
  • 辉瑞公司
  • 赛诺菲
  • Vertellus Holdings LLC
 

North America Pharmaceutical Intermediates Strategic Insights

Strategic insights for North America Pharmaceutical Intermediates involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-pharmaceutical-intermediates-market-strategic-framework.webp
Get more information on this report

North America Pharmaceutical Intermediates Report Scope

Report Attribute Details
Market size in 2021 US$ 11,054.47 Million
Market Size by 2028 US$ 14,927.32 Million
Global CAGR (2021 - 2028) 4.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 类型
  • GMP
  • 非GMP
By 应用
  • 抗生素
  • 解热镇痛药
  • 维生素
By 分销渠道
  • 经销商
  • 直销
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • BASF SE
  • chiracon GmbH
  • Codexis
  • Dishman Carbogen Amcis Ltd
  • Midas Pharma GmbH
  • Pfizer Inc.
  • Sanofi
  • Vertellus Holdings LLC
  • Get more information on this report

    North America Pharmaceutical Intermediates Regional Insights

    The regional scope of North America Pharmaceutical Intermediates refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-pharmaceutical-intermediates-market-geography.webp
    Get more information on this report

    The List of Companies - North America Pharmaceutical Intermediates Market

    1. BASF SE
    2. chiracon GmbH
    3. Codexis
    4. Dishman Carbogen Amcis Ltd
    5. Midas Pharma GmbH
    6. Pfizer Inc.
    7. Sanofi
    8. Vertellus Holdings LLC

     

    Frequently Asked Questions
    How big is the North America Pharmaceutical Intermediates Market?

    The North America Pharmaceutical Intermediates Market is valued at US$ 11,054.47 Million in 2021, it is projected to reach US$ 14,927.32 Million by 2028.

    What is the CAGR for North America Pharmaceutical Intermediates Market by (2021 - 2028)?

    As per our report North America Pharmaceutical Intermediates Market, the market size is valued at US$ 11,054.47 Million in 2021, projecting it to reach US$ 14,927.32 Million by 2028. This translates to a CAGR of approximately 4.4% during the forecast period.

    What segments are covered in this report?

    The North America Pharmaceutical Intermediates Market report typically cover these key segments-

  • 类型 (GMP, 非GMP)
  • 应用 (抗生素, 解热镇痛药, 维生素)
  • 分销渠道 (经销商, 直销)
  • What is the historic period, base year, and forecast period taken for North America Pharmaceutical Intermediates Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmaceutical Intermediates Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in North America Pharmaceutical Intermediates Market?

    The North America Pharmaceutical Intermediates Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • BASF SE
  • chiracon GmbH
  • Codexis
  • Dishman Carbogen Amcis Ltd
  • Midas Pharma GmbH
  • Pfizer Inc.
  • Sanofi
  • Vertellus Holdings LLC
  • Who should buy this report?

    The North America Pharmaceutical Intermediates Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Pharmaceutical Intermediates Market value chain can benefit from the information contained in a comprehensive market report.